BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22785439)

  • 1. The role of the endocannabinoid system in eating disorders: pharmacological implications.
    Marco EM; Romero-Zerbo SY; Viveros MP; Bermudez-Silva FJ
    Behav Pharmacol; 2012 Sep; 23(5-6):526-36. PubMed ID: 22785439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity.
    McLaughlin PJ
    Behav Pharmacol; 2012 Sep; 23(5-6):537-50. PubMed ID: 22743603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
    Grey J; Terry P; Higgs S
    Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite.
    Cooper SJ
    Eur J Pharmacol; 2004 Oct; 500(1-3):37-49. PubMed ID: 15464019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.
    Engeli S
    Handb Exp Pharmacol; 2012; (209):357-81. PubMed ID: 22249824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
    Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
    Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and appetite: food craving and food pleasure.
    Kirkham TC
    Int Rev Psychiatry; 2009 Apr; 21(2):163-71. PubMed ID: 19367510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system and energy metabolism.
    Bellocchio L; Cervino C; Pasquali R; Pagotto U
    J Neuroendocrinol; 2008 Jun; 20(6):850-7. PubMed ID: 18601709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
    Bellocchio L; Mancini G; Vicennati V; Pasquali R; Pagotto U
    Curr Opin Pharmacol; 2006 Dec; 6(6):586-91. PubMed ID: 17027338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment.
    André A; Gonthier MP
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1788-801. PubMed ID: 20541029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid system in food intake and metabolic regulation.
    Jesudason D; Wittert G
    Curr Opin Lipidol; 2008 Aug; 19(4):344-8. PubMed ID: 18607180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the endocannabinoid system: future therapeutic strategies.
    Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
    Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids and Metabolic Disorders.
    Gatta-Cherifi B; Cota D
    Handb Exp Pharmacol; 2015; 231():367-91. PubMed ID: 26408168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids: some like it fat (and sweet too).
    Matias I; Cristino L; Di Marzo V
    J Neuroendocrinol; 2008 May; 20 Suppl 1():100-9. PubMed ID: 18426508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
    Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
    Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy balance regulation by endocannabinoids at central and peripheral levels.
    Quarta C; Mazza R; Obici S; Pasquali R; Pagotto U
    Trends Mol Med; 2011 Sep; 17(9):518-26. PubMed ID: 21816675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How many sites of action for endocannabinoids to control energy metabolism?
    Pagotto U; Cervino C; Vicennati V; Marsicano G; Lutz B; Pasquali R
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S39-43. PubMed ID: 16570104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Endocannabinoid System and Anxiety.
    Lisboa SF; Gomes FV; Terzian AL; Aguiar DC; Moreira FA; Resstel LB; Guimarães FS
    Vitam Horm; 2017; 103():193-279. PubMed ID: 28061971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endocannabinoids in the hypothalamic regulation of visceral function.
    Wenger T; Moldrich G
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):301-7. PubMed ID: 12052044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.